| Plans | Type(1) | Date of grant | Option exercise price (in euros) | Options outstanding at January 1, 2020 | Options cancelled, lapsed or transferred(2) in 2020 | Options exercised in 2020 | Options remaining to be exercised at December 31, 2020 | Of which exercisable at December 31, 2020 | Exercise Deadline | Remaining contract life (in years) |
|---|---|---|---|---|---|---|---|---|---|---|
| Lionlead 3 2013-2016 France et hors France options | Lionlead 3 2013-2016 France et hors France options Type (1)A | Lionlead 3 2013-2016 France et hors France options Date of grant 04/30/2013 | Lionlead 3 2013-2016 France et hors France options Option exercise price (in euros) 52.76 | Lionlead 3 2013-2016 France et hors France options Options outstanding at January 1, 2020 1,091,937 | Lionlead 3 2013-2016 France et hors France options Options cancelled, lapsed or transferred(2) in 2020 (13,726) | Lionlead 3 2013-2016 France et hors France options Options exercised in 2020 - | Lionlead 3 2013-2016 France et hors France options Options remaining to be exercised at December 31, 2020 1,078,211 | Lionlead 3 2013-2016 France et hors France options Of which exercisable at December 31, 2020 1,078,211 | Lionlead 3 2013-2016 France et hors France options Exercise Deadline 04/30/2023 | Lionlead 3 2013-2016 France et hors France options Remaining contract life (in years) 2.33 |
Total of all tranches | Total of all tranches Type (1)
| Total of all tranches Date of grant
| Total of all tranches Option exercise price (in euros)
| Total of all tranches Options outstanding at January 1, 2020 1,091,937 | Total of all tranches Options cancelled, lapsed or transferred(2) in 2020 (13,726) | Total of all tranches Options exercised in 2020
| Total of all tranches Options remaining to be exercised at December 31, 2020 1,078,211 | Total of all tranches Of which exercisable at December 31, 2020 1,078,211 | Total of all tranches Exercise Deadline
| Total of all tranches Remaining contract life (in years)
|
(1) A = stock options; S = share subscription options.
(2) These relate to any transfers between French and foreign plans due to the geographic mobility of beneficiaries.
The vesting period for the above plans has been completed, but the exercise of options remains subject to a continued presence condition until the date of exercise of the options.
2020 | 2019 | |||
|---|---|---|---|---|
Number of options | Average exercise price (in euros) | Number of options | Average exercise price (in euros) | |
Options at January 1 | Options at January 1 2020 1,091,937 | Options at January 1 2019 52.76 | 1,206,242 | 52.76 |
Options exercised(1) | Options exercised(1) 2020 - | Options exercised(1) 2019
| - | |
Cancelled or lapsed options | Cancelled or lapsed options 2020 (13,726) | Cancelled or lapsed options 2019 52.76 | (114,305) | 52.76 |
Options outstanding at December 31 | Options outstanding at December 31 2020 1,078,211 | Options outstanding at December 31 2019 52.76 | 1,091,937 | 52.76 |
Of which exercisable | Of which exercisable 2020 1,078,211 | Of which exercisable 2019 52.76 | 1,091,937 | 52.76 |
2020
|
2019 n/a | 55.78 | ||
(1) Average share price on exercise (in euros)
